Home › Cirrhosis › North Carolina
Pag-aaral pangklinika para sa Cirrhosis sa North Carolina
6 pag-aaral para sa Cirrhosis ang naghahanap ng mga kalahok sa mga site sa North Carolina.
Mga Lungsod sa North Carolina
Opisyal na teksto ng pag-aaral (English)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Duke University Medical Center, Durham
- Coastal Research Institute, LLC, Fayetteville
- Carolina Researche, Greenville
- at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Lucas Research, Inc., Morehead City
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Duke Liver Center, Durham
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- University of North Carolina, Chapel Hill
Nagre-recruitPhase 4
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Morehead City
- Research Site, Raleigh
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07610837Siemens Biomarker Multi-modality
- Duke University Medical Center, Durham
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT07495332Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.